Teva gains as first-quarter profit falls less than expected.

Teva Pharmaceuticals shares gained 5 percent Monday after reporting better-than-expected first-quarter profit as generic drug sales drove performance.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.